Introduction This study aimed to evaluate the frequency rate of extended-spectrum beta-
lactamase-producing Enterobacteriaceae (ESBL-PE) causing bloodstream infections (BSIs) …

Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) are an
increasing cause of resistant infections among patients with malignancy. This study sought …

Introduction: Bloodstream infection (BSI) caused by Enterobacteriaceae is associated with
mortality in cancer patients receiving chemotherapy. The aim of this study is to identify the …

Aim. Given the steadily increasing numbers of resistant bacteria, the frequency and severity
of infections are on the rise. In patients with hematological malignancies, the treatment itself …

Cancer patients are vulnerable to infections, including those with extended-spectrum β-
lactamase-producing Enterobacteriaceae (ESBL-PE), and most of these infections are …

Objectives The aim of the study was to investigate the prevalence of extended-spectrum β-
lactamase and carbapenemase production among Enterobacteriaceae isolated from …

Background: The emergence of extended-spectrum β-lactamase (ESBL)-producing
Escherichia coli and Klebsiella pneumoniae constitutes a serious problem because of the …

Aim: To describe the risk factors and molecular epidemiology of nosocomial bloodstream
infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae …

Objectives: Extended-spectrum beta-lactamases (ESBLs) have been detected more
frequently in members of the Enterobacteriaceae family, particularly Escherichia coli and …

Patients with cancer can be vulnerable to infection with antimicrobial-resistant pathogens
such as extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. A cohort …